Corbus Pharmaceuticals Board Member To Sell Shares In Planned Trading
In a recent move signaling strategic financial planning, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) announced that Dr. Yong Ben, a member of its board of directors, has adopted a Rule 10b5-1 trading plan. This decision, detailed in a Form 8-K filing with the U.S.
